Anti-AP2 alpha + beta抗体[A6/2/2] (ab61)

概述

  • 产品名称Anti-AP2 alpha + beta抗体[A6/2/2]
    参阅全部 AP2 alpha + beta 一抗
  • 描述
    小鼠单克隆抗体[A6/2/2] to AP2 alpha + beta
  • 特异性Reacts with both AP-2 alpha and beta forms. As the antibody also recognises AP2 beta, the epitope it recognises is probably the last 8 amino acids as these are common between alpha and beta.
  • 经测试应用适用于: Flow Cyt, WB, ELISA, IHC-P, RIA, ICC/IFmore details
  • 种属反应性
    与反应: Human
  • 免疫原

    C-terminal peptide of AP-2 alpha (PNSHTDNNAKSSDKEEKHRK).

  • 阳性对照
    • Raji cells or breast carcinoma

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • 存储溶液Phosphate buffered saline
  • Concentration information loading...
  • 纯度Protein A purified
  • 克隆单克隆
  • 克隆编号A6/2/2
  • 骨髓瘤NS0
  • 同种型IgG1
  • 轻链类型unknown
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab61 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
Flow Cyt Use at an assay dependent concentration.

ab170190 - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.

WB Use at an assay dependent concentration. Predicted molecular weight: 48 kDa.
ELISA Use at an assay dependent concentration.
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval via the microwave method before commencing with IHC staining protocol.
RIA Use at an assay dependent concentration.
ICC/IF Use a concentration of 1 µg/ml.

靶标

  • 相关性The AP2 proteins are normally expressed in ectodermally derived vertebrate tissues where they are necessary for normal growth and development. The factors have also been implicated in the control of cell proliferation, viral transformation, and oncogenesis. AP2 seems to play in important role in human breast cancer. AP2 alpha is the only AP2 protein required for early morphogenesis of the lens vesicle. AP2 beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia
  • 细胞定位Nuclear
  • 数据库链接
  • 别名
    • Activating enhancer binding protein 2 alpha antibody
    • Activating enhancer binding protein 2 beta antibody
    • Activator protein 2 antibody
    • AP 2 antibody
    • AP 2alpha antibody
    • AP 2B antibody
    • AP-2 transcription factor antibody
    • AP2 B antibody
    • AP2-alpha antibody
    • AP2-beta antibody
    • AP2TF antibody
    • BOFS antibody
    • TFAP2 antibody
    • TFAP2A antibody
    • TFAP2B antibody
    • Transcription factor AP2 alpha antibody
    • Transcription factor AP2 beta antibody
    see all

Anti-AP2 alpha + beta antibody [A6/2/2] 图像

  • ICC/IF image of ab61 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal Goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab61, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 Goat anti-Mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Anti-AP2 alpha + beta antibody [A6/2/2] (ab61)参考文献

This product has been referenced in:
  • Gee JM  et al. Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol 189:514-20 (1999). Read more (PubMed: 10629551) »

See 1 Publication for this product

Product Wall

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Western blot
Sample Human Cell lysate - nuclear (Hela)
Loading amount 30 µg
Specification Hela
Gel Running Conditions Reduced Denaturing
Username

Abcam user community

Verified customer

提交于 Jul 30 2008

Thank you for your enquiry. Raji cells or breast carcinomas should be a suitable positive control. I hope this information helps. Please do not hesitate to contact us if you need anything further.

The antibody A6/2/2 was raised against the peptide PNSHTDNNAKSSDKEEKHRK which is the C-terminus of AP-2alpha. As the antibody also recognises AP 2beta, the epitope it recognises is probably the last 8 amino acids as these are common between alpha and ...

Read More

We always recommend that conditions for WB should be optimised by the end user. We suggest starting with a 1:1000 dilution.

This antibody recognises the transcription factor AP-2 and thus not the adaptor protein (AP-2).

We don't have any information on this antibody being used in EMSA, but as the immunogen was a C-terminal peptide chances are quite high it will work.

This antibody works in immunohistochemistry with paraffin embedded sections (fixative formal saline with calcium, 10 min microwave treatment required). However it has not been tested for whole mount IHC as you describe.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"